InvestorsHub Logo
Followers 8
Posts 328
Boards Moderated 0
Alias Born 01/11/2014

Re: None

Thursday, 04/03/2014 11:55:26 AM

Thursday, April 03, 2014 11:55:26 AM

Post# of 34575
Nice PR today. 5 times greater tumor killing for the TPIV vaccine versus Neuvax. Billions and billions in potential revenue. $2B for the smallpox stockpile in the past and we know we can make a smallpox vaccine 1000 times better. We have superior technology! It is so obvious to me that TPIV will probably have a future market cap in the tens of billions. It just takes time to get the clinical data compiled. This stock is so undervalued now it is stealing buying shares under $50.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News